Literature DB >> 22378560

Acute liver failure: a rare clinical presentation of visceral leishmaniasis.

Caterina Sagnelli1, Francesca Di Martino, Nicola Coppola, Antonello Crisci, Evangelista Sagnelli.   

Abstract

We recently re-examined a case of Visceral Leishmaniasis, in a 36-year-old caucasian immune-competent men with an unusual clinical presentation. Together with symptoms and signs of a severe acute liver involvement, he presented weight loss, huge spleen enlargement, pancytopenia and increased ?-globulin serum level with a high polyclonal peak. He had no fever, but over-abundant night sweats were frequent. The patient was considered to have liver cirrhosis, and the diagnosis of visceral leishmaniosis was made with a year's delay. From this case report we may learn that, despite an unusual clinical presentation, the diagnosis of visceral leishmaniasis should not be excluded when other characteristic signs and symptoms and laboratory abnormalities are present.

Entities:  

Mesh:

Year:  2012        PMID: 22378560

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  7 in total

1.  Does Leishmaniasis disease alter the parenchyma and protein expression in salivary glands?

Authors:  Aírton M C Júnior; Fernando A de Amorim Carvalho; Weslany de Oliveira Dantas; Luana C L Gomes; Andrezza B S da Silva; Maria M A de Sousa Cavalcante; Ingrid M de Oliveira; Marina de Deus Moura de Lima; Márcia Dos Santos Rizzo; Carla Maria de Carvalho Leite; Selma Maria Dos Santos Moura; Lúcia de Fátima Almeida de Deus Moura; Benedito B da Silva
Journal:  Exp Biol Med (Maywood)       Date:  2015-11-13

2.  Five-year retrospective Italian multicenter study of visceral leishmaniasis treatment.

Authors:  Francesco Di Masi; Tamara Ursini; Maria Donata Iannece; Leonardo Chianura; Francesco Baldasso; Giuseppe Foti; Pietro Di Gregorio; Angelo Casabianca; Nunzio Storaci; Luciano Nigro; Claudia Colomba; Maria Grazia Marazzi; Giovanni Todaro; Giacinta Tordini; Giacomo Zanelli; Giovanni Cenderello; Nicola Acone; Ennio Polilli; Simona Migliore; Paolo Almi; Eligio Pizzigallo; Evangelista Sagnelli; Francesco Mazzotta; Rosario Russo; Lamberto Manzoli; Giustino Parruti
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

3.  Alteration of Clinical Chemistry Parameters Among Visceral Leishmaniasis Patients in Western Tigrai, Ethiopia, 2018/2019: A Comparative Cross-Sectional Study.

Authors:  Brhane Tesfanchal; Gebremedhin Gebremichail; Getachew Belay; Gebreslassie Gebremariam; Gebreyohannes Teklehaimanot; Hagos Haileslasie; Getachew Kahsu; Aderajew Gebrewahd; Fitsum Mardu; Gebre Adhanom; Brhane Berhe; Hirut Teame; Aster Tsegaye; Mistire Wolde
Journal:  Infect Drug Resist       Date:  2020-08-26       Impact factor: 4.003

4.  Hyponatremia and risk factors for death in human visceral leishmaniasis: new insights from a cross-sectional study in Brazil.

Authors:  Elizabeth De Francesco Daher; Douglas de Sousa Soares; Sérgio Luiz Arruda Parente Filho; Gdayllon Cavalcante Meneses; Tainá Veras de Sandes Freitas; Tacyano Tavares Leite; Geraldo Bezerra da Silva Junior
Journal:  BMC Infect Dis       Date:  2017-02-23       Impact factor: 3.090

5.  A Case of Herpes Simplex Virus-1 Encephalitis from a Medicolegal Point of View.

Authors:  Alessandro Feola; Anna Mancuso; Mauro Arcangeli
Journal:  Case Rep Med       Date:  2018-06-10

6.  Acute liver failure due to visceral leishmaniasis in Barcelona: a case report.

Authors:  Iratxe Martinez de Narvajas; Alba Díaz; Octavio Bassegoda; Adriá Carpio; Carla Fuster; María Eugenia Valls; Miriam J Alvarez-Martínez; Carolina García-Vidal; Alejandro Soriano; José Antonio Martínez; Juan Ambrosioni
Journal:  BMC Infect Dis       Date:  2019-10-22       Impact factor: 3.090

7.  Assessment of liver function test and associated factors among visceral leishmaniasis patients attending university of gondar leishmaniasis research and treatment center, Northwest Ethiopia.

Authors:  Hiwot Tezera Endale; Tiget Ayelgn Mengstie; Dilargachew Dessie Dawit; Rezika Mohammed; Gashaw Dessie; Kibur Hunie Tesfa
Journal:  PLoS One       Date:  2021-11-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.